← All trials
NCT01720277
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2012
- Primary completion
- Apr 1, 2013
- Completion date
- Sep 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 210
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Insight Therapeutics, LLCLead sponsor
- Case Western Reserve UniversityOverall official - principal investigator
- Insight Therapeutics, LLCOverall official - principal investigator
- Brown UniversityOverall official - principal investigator
- Healthcentric AdvisorsOverall official - principal investigator
- Brown UniversityCollaborator
- Case Western Reserve UniversityCollaborator
- Healthcentric AdvisorsCollaborator
- Case Western Reserve UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.